Kymera Therapeutics, Inc. (NASDAQ:KYMR) has 249 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Mar, 2026 | 11,699,950 | 2,771,376 | 31.04% | $974,488,873.00 |
| BAKER BROS. ADVISORS LP | 31 Mar, 2026 | 8,657,242 | 0 | 0.00% | $721,061,686.00 |
| Avoro Capital Advisors LLC | 31 Mar, 2026 | 7,474,747 | -7,474,747 | -50.00% | $622,571,678.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 6,060,847 | 6,060,847 | 0.00% | $504,809.00 |
| BVF INC/IL | 31 Mar, 2026 | 5,502,710 | 0 | 0.00% | $458,320,716.00 |
| T. Rowe Price Investment Management, Inc. | 31 Mar, 2026 | 5,464,997 | 4,738,419 | 652.16% | $455,180.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 5,060,876 | 56,781 | 1.13% | $421,520,382.00 |
| Atlas Venture Life Science Advisors, LLC | 31 Mar, 2026 | 4,578,008 | -81,866 | -1.76% | $381,302,286.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 3,889,687 | -523,246 | -11.86% | $323,972,031.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 3,186,830 | -100,000 | -3.04% | $265,431,071.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,880,324 | 2,880,324 | 0.00% | $239,902,186.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 2,874,056 | 2,874,056 | 0.00% | $239,380,124.00 |
| State Street Corp | 31 Mar, 2026 | 2,389,767 | 179,930 | 8.14% | $199,043,693.00 |
| Capital Research Global Investors | 31 Mar, 2026 | 1,673,275 | 112,484 | 7.21% | $139,367,075.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,645,350 | 227,961 | 16.08% | $137,066,393.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,043,583 | -25,655 | -2.40% | $86,920,028.00 |
| UBS Group AG | 31 Mar, 2026 | 1,023,852 | 286,820 | 38.92% | $85,276,632.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 888,409 | -592,203 | -40.00% | $73,995,585.00 |
| ALLIANCEBERNSTEIN L.P. | 31 Mar, 2026 | 888,035 | -64,030 | -6.73% | $69,098,003.00 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 31 Mar, 2026 | 875,872 | -36,626 | -4.01% | $72,951,379.00 |